tiprankstipranks
Trending News
More News >
Diaceutics (GB:DXRX)
LSE:DXRX
UK Market
Advertisement

Diaceutics (DXRX) Ratios

Compare
10 Followers

Diaceutics Ratios

GB:DXRX's free cash flow for Q4 2024 was £0.88. For the 2024 fiscal year, GB:DXRX's free cash flow was decreased by £ and operating cash flow was £0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.80 6.40 8.23 11.41 11.53
Quick Ratio
3.80 6.40 8.23 11.41 11.53
Cash Ratio
1.64 3.80 5.29 7.47 8.66
Solvency Ratio
0.40 0.54 0.65 0.54 0.33
Operating Cash Flow Ratio
0.13 0.30 1.37 0.22 0.09
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 4.38 2.14
Net Current Asset Value
£ 20.77M£ 22.48M£ 25.15M£ 25.70M£ 30.34M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.03 0.03 0.03 <0.01
Debt-to-Equity Ratio
0.03 0.03 0.03 0.04 <0.01
Debt-to-Capital Ratio
0.03 0.03 0.03 0.04 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.22 1.14 1.14 1.11 1.08
Debt Service Coverage Ratio
60.72 46.23 31.59 10.92 8.62
Interest Coverage Ratio
-45.61 -41.18 2.71 3.56 -14.88
Debt to Market Cap
0.00 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
0.01 0.02 0.02 0.02 <0.01
Net Debt to EBITDA
-3.80 -6.55 -5.13 -8.58 -141.22
Profitability Margins
Gross Profit Margin
81.32%83.15%71.97%75.78%73.50%
EBIT Margin
-6.55%-10.01%3.51%3.94%-4.97%
EBITDA Margin
9.56%9.95%18.50%15.15%1.40%
Operating Profit Margin
-7.66%-11.47%1.70%2.24%-4.80%
Pretax Profit Margin
-5.93%-10.29%2.45%2.10%-7.32%
Net Profit Margin
-5.30%-7.37%3.71%4.02%2.07%
Continuous Operations Profit Margin
-5.30%-7.37%3.71%4.02%2.07%
Net Income Per EBT
89.26%71.62%151.46%191.47%-28.31%
EBT Per EBIT
77.47%89.70%144.41%93.61%152.30%
Return on Assets (ROA)
-3.50%-3.77%1.50%1.25%0.60%
Return on Equity (ROE)
-4.33%-4.28%1.70%1.38%0.65%
Return on Capital Employed (ROCE)
-6.03%-6.48%0.74%0.74%-1.50%
Return on Invested Capital (ROIC)
-5.36%-4.62%1.12%1.40%0.42%
Return on Tangible Assets
-5.13%-5.62%2.19%1.74%0.77%
Earnings Yield
-1.65%-2.38%1.14%0.66%0.25%
Efficiency Ratios
Receivables Turnover
2.15 2.34 1.87 0.00 0.00
Payables Turnover
4.94 3.75 7.20 6.58 7.22
Inventory Turnover
0.00 0.00 5.47M 0.00 0.00
Fixed Asset Turnover
19.16 12.48 9.32 6.55 53.34
Asset Turnover
0.66 0.51 0.40 0.31 0.29
Working Capital Turnover Ratio
1.48 0.93 0.71 0.48 0.54
Cash Conversion Cycle
95.85 58.60 144.46 -55.45 -50.56
Days of Sales Outstanding
169.81 155.96 195.13 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 <0.01 0.00 0.00
Days of Payables Outstanding
73.96 97.35 50.67 55.45 50.56
Operating Cycle
169.81 155.96 195.13 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
0.01 0.02 0.06 <0.01 <0.01
Free Cash Flow Per Share
0.01 -0.04 <0.01 -0.06 -0.08
CapEx Per Share
<0.01 0.06 0.06 0.07 0.08
Free Cash Flow to Operating Cash Flow
0.90 -2.70 0.05 -8.83 -23.88
Dividend Paid and CapEx Coverage Ratio
10.00 0.27 1.06 0.10 0.04
Capital Expenditure Coverage Ratio
10.00 0.27 1.06 0.10 0.04
Operating Cash Flow Coverage Ratio
0.94 1.09 3.87 0.37 2.14
Operating Cash Flow to Sales Ratio
0.03 0.06 0.26 0.04 0.02
Free Cash Flow Yield
0.88%-4.84%0.44%-5.88%-5.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-60.45 -41.97 87.75 152.61 393.56
Price-to-Sales (P/S) Ratio
3.19 3.09 3.26 6.14 8.15
Price-to-Book (P/B) Ratio
2.58 1.80 1.49 2.11 2.57
Price-to-Free Cash Flow (P/FCF) Ratio
114.04 -20.68 228.54 -17.02 -17.13
Price-to-Operating Cash Flow Ratio
102.94 55.89 12.34 150.20 409.12
Price-to-Earnings Growth (PEG) Ratio
-1.51 0.12 3.09 1.57 -8.71
Price-to-Fair Value
2.58 1.80 1.49 2.11 2.57
Enterprise Value Multiple
29.59 24.51 12.48 31.96 440.28
Enterprise Value
90.95M 57.82M 45.02M 67.50M 78.37M
EV to EBITDA
29.59 24.51 12.48 31.96 440.28
EV to Sales
2.83 2.44 2.31 4.84 6.17
EV to Free Cash Flow
101.06 -16.31 161.95 -13.42 -12.97
EV to Operating Cash Flow
90.95 44.10 8.75 118.42 309.76
Tangible Book Value Per Share
0.29 0.30 0.32 0.33 0.40
Shareholders’ Equity Per Share
0.47 0.48 0.51 0.48 0.52
Tax and Other Ratios
Effective Tax Rate
0.11 0.28 -0.51 -0.91 1.28
Revenue Per Share
0.38 0.28 0.23 0.17 0.16
Net Income Per Share
-0.02 -0.02 <0.01 <0.01 <0.01
Tax Burden
0.89 0.72 1.51 1.91 -0.28
Interest Burden
0.91 1.03 0.70 0.53 1.47
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.51 0.96 0.83 0.85 0.79
Stock-Based Compensation to Revenue
0.02 0.02 0.03 0.03 0.02
Income Quality
-0.59 -0.75 7.11 1.02 0.96
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis